These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 11169568)

  • 1. Adrenal tumors in BRCA1/BRCA2 mutation carriers.
    Barak F; Shiri-Svredlov R; Bruchim-Bar Sade R; Kruglikova A; Friedman E; Ben-Dor D; Goldberg I
    Am J Med Genet; 2001 Jan; 98(3):277-9. PubMed ID: 11169568
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular characterization of germline mutations in the BRCA1 and BRCA2 genes from breast cancer families in Taiwan.
    Li SS; Tseng HM; Yang TP; Liu CH; Teng SJ; Huang HW; Chen LM; Kao HW; Chen JH; Tseng JN; Chen A; Hou MF; Huang TJ; Chang HT; Mok KT; Tsai JH
    Hum Genet; 1999 Mar; 104(3):201-4. PubMed ID: 10323242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The frequency of the predominant Jewish mutations in BRCA1 and BRCA2 in unselected Ashkenazi colorectal cancer patients.
    Chen-Shtoyerman R; Figer A; Fidder HH; Rath P; Yeremin L; Bar Meir S; Friedman E; Theodor L
    Br J Cancer; 2001 Feb; 84(4):475-7. PubMed ID: 11207040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low proportion of BRCA1 and BRCA2 mutations in Finnish breast cancer families: evidence for additional susceptibility genes.
    Vehmanen P; Friedman LS; Eerola H; McClure M; Ward B; Sarantaus L; Kainu T; Syrjäkoski K; Pyrhönen S; Kallioniemi OP; Muhonen T; Luce M; Frank TS; Nevanlinna H
    Hum Mol Genet; 1997 Dec; 6(13):2309-15. PubMed ID: 9361038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BRCA2 germline mutations among early onset breast cancer patients unselected for family history of the disease.
    Plaschke J; Commer T; Jacobi C; Schackert HK; Chang-Claude J
    J Med Genet; 2000 Sep; 37(9):E17. PubMed ID: 10978364
    [No Abstract]   [Full Text] [Related]  

  • 6. Re-evaluation of benefits of BRCA1/2 testing.
    Knell ER; Presant CA
    J Clin Oncol; 1999 Jun; 17(6):1962. PubMed ID: 10561241
    [No Abstract]   [Full Text] [Related]  

  • 7. BRCA1 and BRCA2 mutation carriers as potential candidates for chemoprevention trials.
    Levy-Lahad E; Krieger M; Gottfeld O; Renbaum P; Klein G; Eisenberg S; Lahad A; Kaufman B; Catane R
    J Cell Biochem Suppl; 2000; 34():13-8. PubMed ID: 10762009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simple and rapid detection of BRCA1 and BRCA2 mutations by multiplex mutagenically separated PCR.
    Chan PC; Wong BY; Ozcelik H; Cole DE
    Clin Chem; 1999 Aug; 45(8 Pt 1):1285-7. PubMed ID: 10430798
    [No Abstract]   [Full Text] [Related]  

  • 9. Biochemical and genetic characterisation shows that the BRCA1 IVS20 insertion is a polymorphism.
    Scholl T; Pyne MT; Ward B; Pruss D
    J Med Genet; 1999 Jul; 36(7):571-2. PubMed ID: 10424822
    [No Abstract]   [Full Text] [Related]  

  • 10. Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2.
    Roa BB; Boyd AA; Volcik K; Richards CS
    Nat Genet; 1996 Oct; 14(2):185-7. PubMed ID: 8841191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Universal DNA array detection of small insertions and deletions in BRCA1 and BRCA2.
    Favis R; Day JP; Gerry NP; Phelan C; Narod S; Barany F
    Nat Biotechnol; 2000 May; 18(5):561-4. PubMed ID: 10802632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A breast/ovarian cancer patient with germline mutations in both BRCA1 and BRCA2.
    Ramus SJ; Friedman LS; Gayther SA; Ponder BA; Bobrow L; van der Looji M; Papp J; Olah E
    Nat Genet; 1997 Jan; 15(1):14-5. PubMed ID: 8988162
    [No Abstract]   [Full Text] [Related]  

  • 13. Parity and breast cancer in BRCA1/BRCA2 carriers.
    Narod S
    Lancet; 2000 Aug; 356(9230):679. PubMed ID: 10968458
    [No Abstract]   [Full Text] [Related]  

  • 14. BRCA1 and BRCA2 mutation analysis in breast-ovarian cancer families from northeastern Poland.
    Perkowska M; BroZek I; Wysocka B; Haraldsson K; Sandberg T; Johansson U; Sellberg G; Borg A; Limon J
    Hum Mutat; 2003 May; 21(5):553-4. PubMed ID: 12673801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Brca1 and Brca2 proteins and tumor pathogenesis.
    Ingvarsson S
    Anticancer Res; 1999; 19(4B):2853-61. PubMed ID: 10652564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutational analyses of BRCA1 and BRCA2 in Ashkenazi and non-Ashkenazi Jewish women with familial breast and ovarian cancer.
    Shiri-Sverdlov R; Oefner P; Green L; Baruch RG; Wagner T; Kruglikova A; Haitchick S; Hofstra RM; Papa MZ; Mulder I; Rizel S; Bar Sade RB; Dagan E; Abdeen Z; Goldman B; Friedman E
    Hum Mutat; 2000 Dec; 16(6):491-501. PubMed ID: 11102978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inherited predisposition to pancreatic adenocarcinoma: role of family history and germ-line p16, BRCA1, and BRCA2 mutations.
    Lal G; Liu G; Schmocker B; Kaurah P; Ozcelik H; Narod SA; Redston M; Gallinger S
    Cancer Res; 2000 Jan; 60(2):409-16. PubMed ID: 10667595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parity, oral contraceptives, and the risk of ovarian cancer among carriers and noncarriers of a BRCA1 or BRCA2 mutation.
    Modan B; Hartge P; Hirsh-Yechezkel G; Chetrit A; Lubin F; Beller U; Ben-Baruch G; Fishman A; Menczer J; Struewing JP; Tucker MA; Wacholder S;
    N Engl J Med; 2001 Jul; 345(4):235-40. PubMed ID: 11474660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High throughput fluorescence-based conformation-sensitive gel electrophoresis (F-CSGE) identifies six unique BRCA2 mutations and an overall low incidence of BRCA2 mutations in high-risk BRCA1-negative breast cancer families.
    Ganguly T; Dhulipala R; Godmilow L; Ganguly A
    Hum Genet; 1998 May; 102(5):549-56. PubMed ID: 9654203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas.
    Goggins M; Schutte M; Lu J; Moskaluk CA; Weinstein CL; Petersen GM; Yeo CJ; Jackson CE; Lynch HT; Hruban RH; Kern SE
    Cancer Res; 1996 Dec; 56(23):5360-4. PubMed ID: 8968085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.